Bonesupport Holding AB (publ)
Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin duri… Read more
Bonesupport Holding AB (publ) (BOEUF) - Net Assets
Latest net assets as of September 2025: $830.14 Million USD
Based on the latest financial reports, Bonesupport Holding AB (publ) (BOEUF) has net assets worth $830.14 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($998.22 Million) and total liabilities ($168.08 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $830.14 Million |
| % of Total Assets | 83.16% |
| Annual Growth Rate | N/A |
| 5-Year Change | 82.37% |
| 10-Year Change | 3478.63% |
| Growth Volatility | 378.61 |
Bonesupport Holding AB (publ) - Net Assets Trend (2014–2024)
This chart illustrates how Bonesupport Holding AB (publ)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bonesupport Holding AB (publ) (2014–2024)
The table below shows the annual net assets of Bonesupport Holding AB (publ) from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $727.46 Million | +33.44% |
| 2023-12-31 | $545.18 Million | +102.72% |
| 2022-12-31 | $268.93 Million | +1.21% |
| 2021-12-31 | $265.70 Million | -33.39% |
| 2020-12-31 | $398.90 Million | +220.89% |
| 2019-12-31 | $124.31 Million | -55.37% |
| 2018-12-31 | $278.53 Million | -38.21% |
| 2017-12-31 | $450.79 Million | +1214.09% |
| 2016-12-31 | $34.30 Million | +68.75% |
| 2015-12-31 | $20.33 Million | +146.71% |
| 2014-12-31 | $-43.52 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bonesupport Holding AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 38296400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $41.73 Million | 5.74% |
| Other Comprehensive Income | $6.58 Million | 0.90% |
| Other Components | $1.57 Billion | 215.26% |
| Total Equity | $727.46 Million | 100.00% |
Bonesupport Holding AB (publ) Competitors by Market Cap
The table below lists competitors of Bonesupport Holding AB (publ) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Wondershare Technology Co Ltd Class A
SHE:300624
|
$1.33 Billion |
|
QCR Holdings Inc
NASDAQ:QCRH
|
$1.33 Billion |
|
Bilfinger SE O.N.
LSE:0NRG
|
$1.33 Billion |
|
Orange Polska S.A
PINK:PTTWF
|
$1.33 Billion |
|
Invisio AB (publ)
F:ICQ
|
$1.32 Billion |
|
SIX FLAGS E.
F:6FE0
|
$1.32 Billion |
|
Lucid Group Inc
NASDAQ:LCID
|
$1.32 Billion |
|
Anand Rathi Wealth Limited
NSE:ANANDRATHI
|
$1.32 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bonesupport Holding AB (publ)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 545,177,000 to 727,464,000, a change of 182,287,000 (33.4%).
- Net income of 133,754,000 contributed positively to equity growth.
- New share issuances of 2,421,000 increased equity.
- Other comprehensive income increased equity by 5,441,999.
- Other factors increased equity by 40,670,001.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $133.75 Million | +18.39% |
| Share Issuances | $2.42 Million | +0.33% |
| Other Comprehensive Income | $5.44 Million | +0.75% |
| Other Changes | $40.67 Million | +5.59% |
| Total Change | $- | 33.44% |
Book Value vs Market Value Analysis
This analysis compares Bonesupport Holding AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.98x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $-0.94 | $32.55 | x |
| 2015-12-31 | $0.44 | $32.55 | x |
| 2016-12-31 | $0.74 | $32.55 | x |
| 2017-12-31 | $11.32 | $32.55 | x |
| 2018-12-31 | $5.46 | $32.55 | x |
| 2019-12-31 | $2.40 | $32.55 | x |
| 2020-12-31 | $6.75 | $32.55 | x |
| 2021-12-31 | $4.15 | $32.55 | x |
| 2022-12-31 | $4.17 | $32.55 | x |
| 2023-12-31 | $8.31 | $32.55 | x |
| 2024-12-31 | $10.92 | $32.55 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bonesupport Holding AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 18.39%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.88%
- • Asset Turnover: 1.02x
- • Equity Multiplier: 1.21x
- Recent ROE (18.39%) is above the historical average (-77.75%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 0.00% | -124.67% | 0.90x | 0.00x | $-46.71 Million |
| 2015 | -292.97% | -96.44% | 0.55x | 5.49x | $-61.59 Million |
| 2016 | -321.22% | -105.35% | 0.55x | 5.50x | $-113.62 Million |
| 2017 | -28.59% | -99.67% | 0.22x | 1.32x | $-173.95 Million |
| 2018 | -63.33% | -182.57% | 0.30x | 1.17x | $-204.26 Million |
| 2019 | -129.56% | -103.60% | 0.79x | 1.58x | $-173.49 Million |
| 2020 | -25.42% | -56.07% | 0.39x | 1.17x | $-141.30 Million |
| 2021 | -32.19% | -40.18% | 0.62x | 1.29x | $-112.10 Million |
| 2022 | -25.35% | -20.73% | 0.88x | 1.38x | $-95.06 Million |
| 2023 | 44.94% | 41.45% | 0.86x | 1.26x | $190.50 Million |
| 2024 | 18.39% | 14.88% | 1.02x | 1.21x | $61.01 Million |
Industry Comparison
This section compares Bonesupport Holding AB (publ)'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,344,700,045
- Average return on equity (ROE) among peers: -67.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bonesupport Holding AB (publ) (BOEUF) | $830.14 Million | 0.00% | 0.20x | $1.33 Billion |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $520.03 Million | 8.62% | 0.25x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $121.35 Million | -35.38% | 0.57x | $16.24 Million |
| Alcon AG (ALC) | $18.82 Billion | -2.82% | 0.47x | $37.83 Billion |
| Align Technology Inc (ALGN) | $93.44 Million | 1.51% | 0.52x | $11.30 Billion |
| AngioDynamics Inc (ANGO) | $405.75 Million | 2.00% | 0.08x | $353.07 Million |
| Ansell Limited (ANSLF) | $1.40 Billion | 7.95% | 0.69x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.24 Billion |
| AtriCure Inc (ATRC) | $15.61 Million | -34.94% | 1.17x | $1.46 Billion |
| Avinger Inc (AVGR) | $-6.20 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $1.86 Million | -634.53% | 4.26x | $156.14 Million |